Alzheimer’s Paper Retracted; Pets and Human Cognition; Long COVID Internal Tremors

— News and commentary from the world of neurology and neuroscience

by
Judy George, Deputy Managing Editor, MedPage Today
January 2, 2024

Nature announced that another Alzheimer’s paper led by former Stanford president Marc Tessier-Lavigne, PhD, was retracted, identifying anomalies in the 2009 study of amyloid precursor protein (APP) and death receptor 6 (DR6) binding. The paper has been cited 814 times.

Clinically apparent Helicobacter pylori infection raised the risk of Alzheimer’s disease in people ages 50 and older. (Alzheimer’s & Dementia)

Owning a pet was associated with slower declines in verbal memory and verbal fluency in older adults who lived alone, but not in those who lived with others. (JAMA Network Open)

Biomarkers of glial injury persisted for more than 6 weeks in hospitalized patients who had neurological complications during acute SARS-CoV-2 infection. (Nature Communications)

The experiences of people with long COVID symptoms that featured internal tremors and vibrations were described in BMJ Open.

A study of more than 10,000 people linked exercise-related physical activity with brain volumes. (Journal of Alzheimer’s Disease)

The U.S. has failed to make changes to its insufficient caregiving system, argued Rachael Scarborough King, PhD, the wife of healthcare activist Ady Barkan who recently died of amyotrophic lateral sclerosis. (New York Times)

Real-world mobility measures in people with Parkinson’s disease were moderately associated with clinical assessments, suggesting wearable sensors may capture different aspects of motor function. (Movement Disorders)

CNN looked at how chronic pain patients found relief with ketamine.

A history of daily smoking was strongly associated with decreased total brain volume. (Biological Psychiatry: Global Open Science)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) advocate and #MEAction cofounder Beth Mazur died after a 15-year battle with ME, the organization announced.

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
한국 쇼트트랙 혼성계주 예선 1회전 충격 탈락 thumbnail

한국 쇼트트랙 혼성계주 예선 1회전 충격 탈락

한국쇼트트랙 대표팀 박장혁이 5일 중국 베이징 캐피털 실내경기장에서 열린 2022 베이징동계올림픽 혼성계주 경기 도중 넘어지며 아쉬워하고 있다. 베이징=연합뉴스 올림픽 신설 종목인 쇼트트랙 혼성계주에서 첫 금메달을 노렸던 한국 대표팀의 예선 1회전에서 충격의 탈락을 당했다. 최민정, 이유빈의 여자대표팀 선수와 황대헌, 박장혁의 남자 선수들이 호흡을 맞춘 한국은 5일 중국 베이징 캐피털 실내경기장에서 열린 2022 베이징동계올림픽 쇼트트랙 혼성계주 준준결승…
Read More
BMW कार ने स्कूटी सवार दो लड़कियों को रौंदा, दोनों की मौत, घटना CCTV में कैद thumbnail

BMW कार ने स्कूटी सवार दो लड़कियों को रौंदा, दोनों की मौत, घटना CCTV में कैद

मध्य प्रदेश के इंदौर में BMW कार से एक शख्स ने स्कूटी सवार दो लड़कियों को टक्कर मार दी. जिससे दोनों की मौत हो गई. इस घटना का खौफनाक वीडियो सामने आया है. वहीं, पुलिस ने त्वरित कार्रवाई करते हुए BMW कार के ड्राइवर गजेंद्र प्रताप सिंह (28) को गिरफ्तार कर लिया है. X खौफनाक
Read More
Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics thumbnail

Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics

Not intended for U.S. and UK Media Berlin, June 5, 2023 – Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas’ LNP technology will support Bayer’s in vivo gene editing and protein replacement programs by specifically delivering RNA
Read More
Index Of News
Total
0
Share